![]() |
|
|
Vol. 282, Issue 1, 452-458, 1997
Department of Pharmacology, New York Medical College, Valhalla, New York
| |
Abstract |
|---|
|
|
|---|
Regulation of prostaglandin endoperoxide synthase-2 (PGHS-2) mRNA
levels by serine-threonine phosphatases was examined in murine
fibrosarcoma methylcholanthrene-101 cells. Okadaic acid (OA), a
serine-threonine phosphatase inhibitor, induced PGE2
production and a significant increase in PGHS-2 immunoreactive protein.
A specific PGHS-2 inhibitor, N-(2-cyclohexyloxy-4-nitrophenyl)
methanesulphonamide, completely abolished the OA-mediated increase in
PGE2 production, which suggests that the PGE2
formed in response to OA was derived from PGHS-2. OA-mediated PGHS-2
mRNA accumulation was observed at 1 hr, remained elevated for 24 hr and
was blocked by actinomycin D, which indicates that OA increases PGHS-2
gene transcription. A significant post-transcriptional mechanism also
contributed to the increased PGHS-2 mRNA accumulation, because the mRNA
half-life was approximately 4 to 5 h in OA-stimulated cells. Tumor
necrosis factor-
, but not OA, activated transcription factor nuclear
factor-
B in methylcholanthrene-101 cells, as demonstrated by
translocation of the nuclear factor-
B complex to the nucleus and
disappearance of the cytoplasmic inhibitory protein, I
B-
. We
conclude that inhibition of serine-threonine phosphatases contributes
to the up-regulation of PGHS-2 expression in an NF-
B-independent
manner.
| |
Introduction |
|---|
|
|
|---|
PGHS is the enzyme that converts
arachidonic acid to prostanoids. Expression of the inducible isoform of
this enzyme, PGHS-2, is highly regulated by inflammatory cytokines and
growth factors (DeWitt and Meade, 1993
; Evett et al., 1993
;
Fletcher et al., 1992
; Ristimaki et al., 1994
).
We have previously shown that TNF-
increases PGHS-2 mRNA
accumulation in fibrosarcoma MCA-101 cells and that transcriptional and
post-transcriptional mechanisms contribute to the increase in PGHS-2
mRNA accumulation induced by this cytokine (Mahboubi et al.,
1997
, in press). Moreover, PGE2 production in response to
TNF-
is mainly dependent on PGHS-2 and is regulated by protein
tyrosine kinases and phosphatases (Mahboubi et al., 1997
, in
press). The importance of serine-threonine protein phosphatases in
TNF-
signal transduction pathways is suggested by the similarity in
the pattern of phosphorylation of cellular proteins induced by TNF-
and OA, a noncompetitive inhibitor of PP2A and PP1 serine-threonine phosphatases (Guy et al., 1992
; Fujiki and Suganuma, 1994
).
Moreover, Guy et al. reported that a serine/threonine
phosphatase of primary human fibroblasts is inactivated by TNF-
and
OA (Guy et al., 1993
). OA acid inhibits PP1 about 50 to 100 times less than PP2A, leading to an increase in the phosphorylation of
many cellular proteins (Guy et al., 1992
), and induces
expression of mRNA for many genes by enhancing gene transcription
and/or increasing stability of mRNA (Cao et al., 1992
; Xia
et al., 1993
; Kim et al., 1990
; Pshenichkin and
Wise, 1995
). The contribution of serine-threonine phosphatases to the
expression of PGHS-2 has not been determined.
Increased protein phosphorylation by OA activates several transcription
factors, including NF-
B (Menon et al., 1995
; Rieckmann et al., 1992
; Suzuki et al., 1994
; Menon et
al., 1993
), AP-1 (Rieckmann et al., 1992
; Thevenin
et al., 1991
), Sp1 (Vlach et al., 1995
) and CRE
(Wadzinski et al., 1993
), all of which are regulated by phosphorylation. NF-
B is a transcription factor that regulates the
expression of a variety of genes and exists in the cytoplasm of resting
cells as a heterodimer composed of two polypeptides of 50 kDa (p50) and
65 kDa (p65), which are associated with a cytoplasmic inhibitory
protein, I
B-
(Siebenlist et al., 1994
). Upon
stimulation with a variety of inducers, including TNF-
(Miyamoto et al., 1994
; Finco et al., 1994
; Beg et
al., 1993
) and OA (Menon et al., 1995
; Rieckmann
et al., 1992
; Suzuki et al., 1994
; Menon et
al., 1993
), I
B-
is phosphorylated and subsequently degraded, which makes possible the translocation of NF-
B to the nucleus, where
it binds to
B consensus sequences and initiates gene transcription. A binding site for NF-
B has been identified within the PGHS-2 promoter (Tazawa et al., 1994
; Sirois et al.,
1993
). Yamamoto et al. (1995)
demonstrated a role of NF-
B
in the induction of PGHS-2 by TNF-
in MC3T3-E1 cells. NF-
B also
appears to contribute to TNF-
-mediated induction of PGHS-2 in
MCA-101 cells (K. Mahboubi and N. R. Ferreri, unpublished
observations).
Post-transcriptional mechanisms may be important in the regulation of
PGHS-2. The 3
-untranslated region of the mouse PGHS-2 mRNA has
multiple adenosine-uridine (AU) repeats responsible for shortening the
half-life of PGHS-2 mRNA (Kujubu et al., 1991
). Consequently, increasing PGHS-2 mRNA stability may result in the accumulation of mRNA. For instance, IL-1 (Srivastava et al.,
1994
) and TNF-
(Mahboubi et al., 1997
, in press) increase
PGHS-2 mRNA half-life in renal mesangial and fibrosarcoma MCA-101
cells, respectively. The factors involved in PGHS-2 mRNA stabilization
or degradation have not been characterized. However, Srivastava
et al. showed that IL-1 induces phosphorylation of cytosolic
factors that may extend PGHS-2 mRNA half-life by binding to AU-rich
regions of this mRNA (Srivastava et al., 1994
).
In the present study, we evaluated the importance of serine-threonine
phosphatases in the regulation of PGHS-2 in MCA-101 cells. Inhibition
of serine-threonine phosphatases by OA results in PGHS-2-dependent
formation of PGE2 via NF-
B-independent
transcriptional and post-transcriptional mechanisms. These data suggest
that subsets of transcription factors may differentially contribute to
regulation of PGHS-2 gene transcription, depending on the cell type and
activation signals.
| |
Materials and Methods |
|---|
|
|
|---|
Cell lines and reagents.
MCA-101 (a kind gift from Dr.
Nicholas Restifo, NCI) is a fibrosarcoma cell line of B6 origin that
was generated in 8-week-old female C57BL/6n (B6) mice by i.m. injection
of 0.1% 3-MCA in sesame seed oil. Tumor cell lines were passaged in B6
mice (Restifo et al., 1992
). Tumors were harvested from
mice, digested and maintained in monolayer culture in media consisting
of RPMI 1640, 10% heat-inactivated fetal calf serum (Gemini,
Calabasas, CA), 0.1 mM nonessential amino acids, 1.0 mM sodium
pyruvate, 50 mM 2-mercaptoethanol, 2 mM L-glutamine,
penicillin (100 U/ml) and streptomycin (100 mg/ml). Jurkat T cells, a
human T cell leukemia cell line, was a kind gift from Dr. Nancy Ruddle,
Yale University. Recombinant mouse TNF-
was purchased from Genzyme
(Boston, MA). Sodium orthovanadate, MTT and ACD were from Sigma
Chemical Co. (St. Louis, MO). OA and calyculin A were purchased from LC
Lab (Woburn, MA). NS-398 was purchased from Biomol (Plymouth Meeting,
PA). The PGHS-2 cDNA probe was obtained from Oxford (Oxford, MI).
Measurement of PGE2.
Confluent, quiescent
MCA-101 cells were incubated in the absence or presence of OA in media
containing 0.5% serum for 24 hr, after which the supernates were
assayed for PGE2 by enzyme-linked immunoassay (Oxford, MI)
(Farman et al., 1987
). Briefly, 50 µl of diluted media and
50 µl of HRP-conjugated PGE2 were added for 1 hr to wells
of a 96-well plate that had previously been coated with
anti-PGE2 antibody. After incubation, substrate for HRP was added to each well for 30 min, and the reaction was stopped by addition
of 1 N HCl. Quantitation was achieved by measuring absorbance at 450 nm. Protein concentration in each well was determined by the Bradford
method.
Western blot analysis of PGHS-2. After the appropriate treatment with OA, the media were removed and cells washed twice with ice-cold PBS. Cells were harvested and centrifuged at 600 × g for 4 min in the cold room. The pellet was lysed using RIPA buffer (PBS, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM PMSF, 10 µg/ml leupeptin, 1 mM sodium orthovanadate) for 30 min on ice. The lysate was centrifuged at 10,000 × g for 20 min at 4°C. Protein concentrations of the supernatant were determined using a detergent-compatible Bio-Rad protein assay kit. Then 20 µg of cell lysate was dissolved in an equal volume of 2X SDS-PAGE (SDS-polyacrylamide gel electrophoresis) sample buffer (100 mM Tris-Cl, pH 6.8, 200 mM dithiothreitol, 4% SDS, 0.2% bromophenol blue, 20% glycerol) and boiled for 3 min. The proteins in the cell lysate were separated on a 10% SDS-PAGE gel and transferred to nitrocellulose. Nonspecific sites on the membrane were blocked by incubating the membrane in blocking solution containing 3% nonfat dry milk in TBST at room temperature for 30 min. Membranes were immunoblotted with a rabbit anti-PGHS-2 polyclonal antibody (Cayman, Ann Arbor, MI) for 1 hr at room temperature. Membranes were washed with TBST and incubated with HRP-conjugated goat-anti rabbit antisera (Santa Cruz, CA) for 30 min at room temperature. Membranes were washed, and PGHS-2 protein was detected by the ECL system (Amersham, Arlington Heights, IL).
Western blot analysis of I
B-
.
Cell lysates and gel
electrophoresis were prepared as indicated above. After blocking,
membranes were immunoblotted with rabbit anti-human I
B-
antibody
(Santa Cruz Biotechnology, Santa Cruz, CA) at 1 µg/ml in blocking
solution for 45 min and washed two times for 7 min with TBST. Membranes
were incubated with HRP-conjugated goat anti-rabbit antisera (Santa
Cruz Biotechnology, Santa Cruz, CA) and diluted in blocking solution
for 30 min at room temperature. Membranes were washed with TBST, and
I
B-
protein was detected by the ECL system.
Total RNA isolation and Northern blot analysis.
Confluent,
quiescent cells were incubated in the absence or presence of OA in
media containing 0.5% serum. After various incubation periods, media
were removed and the cell monolayers washed twice with ice-cold PBS.
Total cellular RNA was isolated by lysing the cells in guanidine
isothiocyanate sodium citrate buffer and extracting RNA with ethanol as
described previously (Kamdar and Evans, 1992
). Then 10 µg of RNA were
electrophoresed in a 1% agarose/formaldehyde gel in 1X MOPS
(3-[N-morpholino]propane sulfonic acid) as running buffer. RNA was
transferred to a nylon membrane (Genescreen, Dupont-New England
Nuclear, Boston, MA) and hybridized to a random-primed 32P-labeled cDNA probe in buffer containing 50% formamide,
10% dextran sulfate, 0.2% polyvinylpyrrolidone, 0.2% ficoll, 0.2%
bovine serum albumin, 1.0 M NaCl, 1.0% SDS, 0.05 M Tris, pH 7.5 and
0.1% sodium phosphate at 42°C for 24 hr. After hybridization, the
membrane was washed with 2X SSC (standard sodium citrate), 1.0% SDS at 65°C for 1 hr and with 0.1% SSC at 25°C for 1 hr. Then the probed blots were exposed at
70°C to XAR-5 X-ray film (Eastman Kodak, Rochester, NY).
Nuclear extraction and EMSA.
Nuclear protein extracts were
prepared following the method of Schreiber et al. (1989)
.
Cells were washed twice in ice-cold PBS and then harvested in buffer A
(20 mM HEPES, pH 8.0, 0.32 M sucrose, 2.0 mM CaCl2, 2.0 mM
MgCl2, 0.1 mM EDTA, 0.5% Nonidet P-40, 1.0 mM DTT
(dithiothreitol), 0.25 mM PMSF, 1 µg/ml leupeptin), and nuclei were
pelleted by centrifugation at 1500 × g for 5 min at
4°C. Pelleted nuclei were resuspended in 50 µl of buffer B (20 mM
HEPES, pH 8.0, 25% glycerol, 0.42 M NaCl, 2 mM MgCl2, 0.2 mM EDTA, 1.0 mM DTT, 0.25 mM PMSF, 1 µg/ml leupeptin). Nuclei pellets
were gently mixed and incubated on ice for 15 min. Nuclear debris was
removed by centrifugation for 15 min at 10,000 × g, and nuclear protein concentration was measured by the Bradford method.
B oligonucleotide
(5
...AGTTGAGGGGACTTTCCCAGGC, Promega, Madison, WI) was
5
-end-labeled using [
-32]ATP (specific activity 3000 Ci/mmol, Amersham, Arlington Heights, IL) and T4 polynucleotide kinase
(Clontech, Palo Alto, CA). The unincorporated [
-32]ATP
was separated from labeled probe by electrophoresis in a 15%
polyacrylamide gel. The labeled NF-
B was extracted with
phenol/chloroform followed by ethanol precipitation. The final pellet
was dissolved in Tris-EDTA buffer, pH 7.4. Binding reaction mixtures
containing 20 µg of protein of nuclear extract,
32P-labeled NF-
B probe and 2 µg of calf thymus DNA in
binding buffer (20 mM HEPES, pH 8.0, 5 mM DTT, 0.2 mM EDTA, 0.2 mM
PMSF, 2 mM MgCl2, 10% glycerol, 1 µg/ml leupeptin) were
incubated at room temperature for 20 min. Samples were analyzed by
using native 6% polyacrylamide gels followed by autoradiography.
Cytotoxicity assay.
MCA-101 cells were cultured in 96-well
plates (2.5 × 105 per well) overnight. The following
day, media were removed, and new media containing various drugs or
media were added for 4 hr. At the end of the incubation periods, the
viability of the cells was determined by assaying their metabolic
capacity using MTT (Mosmann, 1983
). Briefly, MTT at 1 mg/ml was added
to all the wells. After a 2-hr incubation at 37°C/5% CO2
in the presence of MTT, acidified isopropanol was added to each well,
and the plates were read using a test wavelength of 570 nm and a
reference wavelength of 630 nm.
| |
Results |
|---|
|
|
|---|
OA increases PGE2 synthesis via
PGHS-2.
OA was used to investigate whether intracellular
serine-threonine phosphatases regulate the expression of PGHS-2. Our
first approach was to determine the effects of OA on PGE2
synthesis. Confluent, quiescent cells were incubated with media
containing 0.5% serum (control) or 100 nM OA for 24 hr. OA at a
concentration of 100 nM was selected because it inhibited approximately
80% of total phosphatase activity in MCA-101 cell lysates (data not shown). Treatment with OA significantly increased PGE2
synthesis (fig. 1) and did not affect cell viability, as
determined by MTT assay and trypan blue exclusion. We determined
whether the OA-induced PGE2 production was associated with
increased PGHS-2 activity in experiments in which MCA-101 cells were
incubated with OA in the presence of NS-398, a selective inhibitor of
PGHS-2 (Futaki et al., 1994
; Copeland et al.,
1994
). NS-398 (0.01 µM) completely abolished the OA-mediated
PGE2 production but had no effect on PGE2
production by unstimulated cells (fig. 1). Thus, OA-induced PGE2 synthesis may have occurred via a
PGHS-2-dependent mechanism.
|
Time- and dose-dependent increase in PGHS-2 protein
expression.
Confluent, quiescent cells were incubated with media
in the presence or absence of 100 nM OA for various times. After
incubation with OA, cells were lysed and analyzed for PGHS-2 protein by
Western blot analysis using a specific PGHS-2 antibody. As shown
previously (Mahboubi et al., 1997
, in press), low levels of
PGHS-2 protein were detected in unstimulated cells (fig.
2A). After challenge with OA, increased levels of PGHS-2
protein were observed at approximately 4 hr and remained elevated up to
24 hr (fig. 2A). Dose-response experiments with OA revealed that 10 nM
OA significantly induced PGHS-2 protein expression and that 0.1 nM OA
did not increase PGHS-2 protein levels (fig. 2B). OA at 10 nM and 0.1 nM inhibited phosphatase activity in MCA-101 cell lysates by
approximately 60% and 50%, respectively (data not shown). Expression
of PGHS-2 was maximal in response to 50 nM OA (fig. 2B).
|
OA increases PGHS-2 mRNA accumulation in a time-dependent
manner.
We investigated whether accumulation of PGHS-2 mRNA could
contribute to the augmentation of PGE2 synthesis and PGHS-2
protein expression observed after stimulation of MCA-101 cells with OA. Confluent, quiescent cells were incubated with OA, and total RNA was
isolated at zero (control), 1, 5, 8, 12, and 24 hr after the addition
of OA (100 nM). PGHS-2 mRNA (4.2 kb) was detected in unstimulated
cells; mRNA accumulation was similar at each of the time-points tested
(fig. 3A). PGHS-2 mRNA accumulation was evident within 1 hr after stimulation with OA, increased dramatically up to 12 hr and
was followed by a slight reduction at 24 hr (fig. 3A). Calyculin A,
another inhibitor of PP1 and PP2A, increased PGHS-2 mRNA accumulation
in MCA-101 cells (fig. 3B).
|
OA increases PGHS-2 mRNA accumulation by transcriptional and
post-transcriptional mechanisms.
The enhancement of PGHS-2 mRNA
accumulation after OA treatment may be explained by enhanced gene
transcription and/or stabilization of message. To test the first
possibility, we arrested transcription with ACD treatment before the
addition of OA and assessed PGHS-2 mRNA levels by Northern blot
analysis. In the presence of ACD, OA-mediated PGHS-2 mRNA accumulation
was significantly reduced (fig. 4). These results
indicate that induction of PGHS-2 mRNA in response to OA was due, at
least in part, to transcriptional regulation of the PGHS-2 gene. We
also determined whether OA could increase PGHS-2 mRNA by prolonging
message half-life. To determine PGHS-2 mRNA half-life in response to
OA, MCA-101 cells were challenged with 100 nM OA (5 hr), and
transcription was subsequently arrested by addition of 1.0 µM ACD.
Cells were harvested at different times after the addition of ACD to
assess mRNA half-life. The levels of PGHS-2 mRNA induced by OA
decreased as a function of time in the presence of ACD (fig.
5). Because ACD blocks gene transcription, the amount of
mRNA remaining at the various time-points is an index of mRNA
half-life. PGHS-2 mRNA half-life of OA-stimulated cells was
approximately 4 to 5 hr (fig. 5). We previously showed that the
half-life of PGHS-2 mRNA in phorbol 12-myristate 13-acetate-stimulated MCA-101 cells is approximately 1 hr (Mahboubi et al., 1997
,
in press). These data suggest that OA-dependent enhancement of the steady-state levels of PGHS-2 mRNA is associated with transcriptional activation and stabilization of the message.
|
|
Effects of OA on NF-
B activation in MCA-101 cells.
OA
activates NF-
B in a variety of cell types, including Jurkat T cells
and fibroblasts (Menon et al., 1995
; Suzuki et
al., 1994
; Menon et al., 1993
; Sun et al.,
1995
). We evaluated the effects of OA on NF-
B activation in MCA-101
cells. Jurkat cells (positive control cell line) and MCA-101 cells were
stimulated with 100 nM OA for 1, 2, or 4 hr. After incubation, cells
were lysed, and NF-
B activity was measured by EMSA. TNF-
is a
potent activator of NF-
B in a wide variety of cell types (Miyamoto
et al., 1994
; Finco et al., 1994
; Beg et
al., 1993
; Henkel et al., 1993
), so nuclear extracts
from TNF-
-stimulated MCA-101 cells were used as a positive control
for NF-
B activation. OA and TNF-
increased NF-
B DNA binding
activity in Jurkat T cells (fig. 6). In contrast,
NF-
B binding activity was detected in nuclear extracts prepared from
TNF-
, but not OA-stimulated MCA-101 cells (fig. 6). Moreover, no
NF-
B binding activity was detected in MCA-101 nuclear extracts after
challenge with 500 nM OA for a range of different time periods (data
not shown). These results suggest that OA does not activate NF-
B in
MCA-101 cells.
|
OA does not stimulate I
B-
degradation in MCA-101 cells.
Activation of NF-
B from cytoplasmic pools should be associated with
proteolytic degradation of the inhibitory I
B-
, according to known
mechanisms of NF-
B activation. To confirm that OA does not activate
NF-
B in MCA-101 cells, we determined its effects on I
B-
protein degradation. Confluent, quiescent MCA-101 cells were incubated
with media (control) or 100 nM OA for various times. After incubation,
cells were lysed, and I
B-
protein was assessed by Western blot
analysis using a specific I
B-
protein antibody. I
B-
protein
was present in unstimulated cells (control) (fig. 7A).
There was no change in I
B-
protein levels after treatment with OA
(fig. 7A). On the other hand, I
B-
protein levels were slightly or
completely reduced, respectively, after a 5- or 10-min stimulation with
TNF-
(fig. 7B). Complete degradation of I
B-
protein, after a
15-min treatment with TNF-
, resulted in the activation of NF-
B
and the translocation of NF-
B heterodimer to the nucleus (fig. 7B;
fig. 6). After a 30-min stimulation with TNF-
, I
B-
protein was
again detected, because of its NF-
B-dependent synthesis. OA causes
I
B-
protein degradation in Jurkat cells (fig. 7C) and induces
translocation of NF-
B to the nucleus (fig. 6). These results are in
agreement with the data obtained by EMSA and indicate that OA does not
induce degradation of I
B-
protein, a prerequisite for activation
of NF-
B.
|
| |
Discussion |
|---|
|
|
|---|
We demonstrated that the inhibition of PP1 and PP2A by OA
increased PGHS-2-dependent PGE2 production, PGHS-2 protein
expression, PGHS-2 gene transcription and PGHS-2 mRNA stability. These
data are the first to show that inhibition of serine-threonine
phosphatases up-regulates the expression of PGHS-2. Moreover,
inhibition of PP1 and PP2A is not sufficient to activate NF-
B in
MCA-101 cells and therefore increases PGHS-2 by an NF-
B-independent
mechanism.
Treatment of MCA-101 cells with 100 nM OA, a dose that inhibited
phosphatase activity in vitro by approximately 80% (data not shown), markedly increased PGE2 synthesis by these
cells. Ohuchi et al. (1989)
showed that OA increased
PGE2 production in macrophages, an effect that was
inhibited in the presence of cycloheximide, which suggests that protein
synthesis was needed for the stimulation of arachidonic acid metabolism
(Ohuchi et al., 1989
). These authors did not determine the
relative contribution of PGHS-1 and PGHS-2 in OA-induced
PGE2 synthesis. OA failed to increase PGE2
synthesis in the presence of NS-398, a result that indicates a possible
role for PGHS-2 in the OA-mediated increase in PGE2
synthesis in MCA-101 cells. Interestingly, OA increased PGHS-2 protein
synthesis and PGHS-2 mRNA levels without affecting PGHS-1 protein
levels in MCA-101 cells (data not shown). Induction of PGHS-2 mRNA by
OA was inhibited in the presence of ACD, which indicates that OA
increases PGHS-2 mRNA by activating transcription of the PGHS-2 gene.
These results suggest that inhibition of PP1 and PP2A may be important
in regulating PGHS-2 gene transcription in MCA-101 cells. Because
NF-
B was not activated by OA in MCA-101 cells, a role for this
transcription factor in OA-induced PGHS-2 gene transcription in these
cells seems unlikely. However, TNF-
caused degradation of I
B-
protein and activation of NF-
B and has previously been linked to the
increase in PGHS-2 mRNA in MCA-101 cells (Mahboubi et al.,
1997
, in press). NF-
B is involved in the TNF-
-dependent induction
of PGHS-2 in MC3T3-E1 cells (Yamamoto et al., 1995
). Thus,
although NF-
B may be involved in the TNF-
-mediated increase in
PGHS-2 in MCA-101 cells, it is not required for the OA-mediated
increase in PGHS-2 mRNA accumulation. OA has been shown to activate Sp1
(Vlach et al., 1995
) and CRE (Wadzinski et al.,
1993
), two transcription factors that are present in the PGHS-2
promoter (Tazawa et al., 1994
). CRE was shown to act as positive regulatory element for PGHS-2 gene transcription (Xie et
al., 1994
; Inoue et al., 1994
). Activation of these
transcription factors by OA may be responsible for OA-induced PGHS-2
gene transcription in MCA-101 cells. The effects of OA on the
activation of CRE and Sp1 and other transcription factors, which may
play a role in regulating transcription of PGHS-2, remain to be
determined.
The 3
-untranslated region of the mouse PGHS-2 mRNA has multiple AU
repeats responsible for shortening the half-life of many unstable mRNAs
(Kujubu et al., 1991
; Malter, 1989
). The stability of
AU-rich mRNAs is regulated by the activity of proteins designated AUBF.
Phosphorylation of AUBF results in its activation and binding to labile
mRNAs and the formation of a complex that is resistant to degradation
(Malter and Hong, 1991
). Previously, we have shown that TNF-
increases PGHS-2 mRNA half-life in MCA-101 cells (Mahboubi et
al., 1997
, in press). Stephens et al. (1992)
demonstrated that OA and TNF-
up-regulate AUBF activity in 3T3-L1
preadipocytes cells, which subsequently results in stabilization of
glucose transporter mRNA for in these cells. As shown in the present
study, OA enhances PGHS-2 mRNA stability, which suggests that an
increase in total serine-threonine phosphorylation by OA decreases the rate of degradation of PGHS-2 mRNA and contributes to its accumulation. Therefore, increased activity of an unidentified AUBF by OA and TNF-
may increase PGHS-2 mRNA stability in MCA-101 cells.
OA activates NF-
B in several cell types, including Jurkat T cells
(Suzuki et al., 1994
; Sun et al., 1995
). However,
OA did not activate NF-
B or induce degradation of I
B-
in
MCA-101 cells. Taken together, these data suggest that inhibition of
serine-threonine phosphatases by OA is not sufficient for the release
of NF-
B from its inhibitor, I
B-
, in MCA-101 cells. Serine
phosphorylation of I
B-
, an event that is essential for its
degradation (Miyamoto et al., 1994
), is achieved by an
increase in serine-threonine kinase activity and/or inhibition of
serine-threonine phosphatase activity. However, inhibition of
phosphatases increases I
B-
phosphorylation only if kinases are
activated. Therefore, it is possible that the serine-threonine kinase
responsible for phosphorylation of I
B-
is not active in
unstimulated MCA-101 cells. Interestingly, previous reports have
suggested that OA-induced activation of NF-
B is dependent on the
endogenous redox status of cells. For instance, Menon and co-workers
(1993) found that OA was unable to activate NF-
B in primary
fibroblasts and that oxidizing agents made possible the induction of
NF-
B by OA in these cells. Thus the inability of OA to activate
NF-
B in MCA-101 cells may be due to high intracellular levels of
antioxidant molecules. In contrast, OA-mediated NF-
B activation in
Jurkat cells, which are highly susceptible to changes in the
intracellular redox state, may have been due to low intracellular
levels of antioxidants (Droge et al., 1994
).
In this study, we illustrated the importance of serine-threonine
phosphorylation to the regulation of PGHS-2 mRNA expression. We
previously showed that signal transduction via protein tyrosine kinase(s) and protein tyrosine phosphatase(s) is required for TNF-
-mediated increases in PGHS-2 mRNA accumulation in MCA-101 cells
(Mahboubi et al., 1997
, in press). Thus more than one
signaling pathway may initiate PGHS-2 gene transcription in MCA-101
cells. Moreover, Guy et al. suggested that TNF-
signal
transduction may involve the tyrosine phosphorylation of PP2A, an event
that causes inactivation of PP2A (Guy et al., 1995
; Guy
et al., 1993
; Chen et al., 1992
). Therefore, it
is also possible that inhibition of PP2A by TNF-
is an important
event in the TNF-
-mediated increase in PGHS-2 mRNA accumulation in
MCA-101 cells.
| |
Acknowledgments |
|---|
We thank Dr. Kenneth M. Lerea for his assistance with the phosphatase assay.
| |
Footnotes |
|---|
Accepted for publication March 21, 1997.
Received for publication January 10, 1997.
Send reprint requests to: Dr. Keyvan Mahboubi, Department of Pharmacology, New York Medical College, Valhalla, NY 10595.
| |
Abbreviations |
|---|
PGHS-2, prostaglandin endoperoxide synthase-2;
OA, okadaic acid;
ACD, actinomycin D;
NF-
B, nuclear factor-
B;
PP1, protein phosphatase 1;
PP2A, protein phosphatase 2A;
MCA, methylcholanthrene;
TNF-
, tumor necrosis factor-
;
IL-1, interleukin-1;
HRP, horseradish peroxidase;
TBST, Tris-buffered saline
Tween;
SDS, sodium dodecyl sulfate;
PBS, phosphate-buffered saline;
ECL, enhanced chemiluminescence;
EMSA, electrophoresis mobility shift
assay;
CRE, cyclic AMP response element;
AUBF, adenosine-uridine
binding factor;
PMSF, phenylmethylsulfonyl fluoride;
MTT, 3-(4,5-dimethylthiazol-2-yl)2,5 diphenyltetrazolium;
NS-398, N-(2-cyclohexyloxy-4-nitrophenyl) methanesulphonamide.
| |
References |
|---|
|
|
|---|
B
: A mechanism for NF-
B activation.
Mol. Cell. Biol.
13: 3301-3310, 1993
, 6-keto-PGF1
, and TXB2 synthesis along the rabbit nephron.
Am. J. Physiol.
252: F53-F59, 1987
-B
is not sufficient for its dissociation from NF-
B and is inhibited by protease inhibitors.
Proc. Natl. Acad. Sci. U.S.A.
91: 11884-11888, 1994
, a new tumor promoter, engendered by biochemical studies of okadaic acid.
J. Biochem.
115: 1-5, 1994
B-
is necessary for activation of transcription factor NF-
B.
Nature
365: 182-185, 1993[Medline].
-dependent regulation of prostaglandin endoperoxide
synthase-2. Cytokine (in press), 1997.
B by protein phosphatase inhibitors in primary and transformed human cells.
J. Biol. Chem.
268: 26805-26812, 1993
B-
serine phosphorylation in nuclear factor
B activation by tumor necrosis factor.
J. Biol. Chem.
270: 18881-18887, 1995
-induced phosphorylation of I
B
is a signal for its degradation but not dissociation from NF-
B.
Proc. Natl. Acad. Sci. U.S.A.
91: 12740-12744, 1994
elicits CD8+ T cells against the wild-type tumor: Correlation with antigen presentation capability.
J. Exp. Med.
175: 1423-1431, 1992
B and tumor necrosis factor-
in human B lymphocytes.
Biochem. Biophys. Res. Commun.
187: 51-57, 1992[Medline].
.
J. Biol. Chem.
269: 11769-11775, 1994
B.
Annu. Rev. Cell Biol.
10: 405-455, 1994.
stabilizes COX II mRNA in renal mesangial cells: Role of 3
-untranslated region.
Am. J. Physiol.
267: F504-F508, 1994
-induced glucose transporter (GLUT-1) mRNA stabilization in 3T3-L1 preadipocytes.
J. Biol. Chem.
267: 8336-8341, 1992
B by phosphatase inhibitors involves the phosphorylation of I
B
at phosphatase 2A-sensitive sites.
J. Biol. Chem.
270: 18347-18351, 1995
B activation.
J. Immunol.
153: 5008-5015, 1994[Abstract].
-B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.
Virology
208: 753-761, 1995[Medline].
(TNF-
) and lymphotoxin (TNF-
) production by protein phosphatase 1 and 2A inhibitor.
Blood
82: 2806-2812, 1993
B and nuclear factor interleukin-6 in the tumor necrosis factor
-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells.
J. Biol. Chem
270: 31315-31320, 1995This article has been cited by other articles:
![]() |
A. E. Kray, R. S. Carter, K. N. Pennington, R. J. Gomez, L. E. Sanders, J. M. Llanes, W. N. Khan, D. W. Ballard, and B. E. Wadzinski Positive Regulation of I{kappa}B Kinase Signaling by Protein Serine/Threonine Phosphatase 2A J. Biol. Chem., October 28, 2005; 280(43): 35974 - 35982. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Mifflin, J. I. Saada, J. F. Di Mari, J. D. Valentich, P. A. Adegboyega, and D. W. Powell Aspirin-Mediated COX-2 Transcript Stabilization via Sustained p38 Activation in Human Intestinal Myofibroblasts Mol. Pharmacol., February 1, 2004; 65(2): 470 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Molenaar, S. Bartel, A. Cochrane, D. Vetter, H. Jalali, P. Pohlner, K. Burrell, P. Karczewski, E.-G. Krause, and A. Kaumann Both {beta}2- and {beta}1-Adrenergic Receptors Mediate Hastened Relaxation and Phosphorylation of Phospholamban and Troponin I in Ventricular Myocardium of Fallot Infants, Consistent With Selective Coupling of {beta}2-Adrenergic Receptors to Gs-Protein Circulation, October 10, 2000; 102(15): 1814 - 1821. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Ferreri, S.-J. An, and J. C. McGiff Cyclooxygenase-2 expression and function in the medullary thick ascending limb Am J Physiol Renal Physiol, September 1, 1999; 277(3): F360 - F368. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kaumann, S. Bartel, P. Molenaar, L. Sanders, K. Burrell, D. Vetter, P. Hempel, P. Karczewski, and E.-G. Krause Activation of ß2-Adrenergic Receptors Hastens Relaxation and Mediates Phosphorylation of Phospholamban, Troponin I, and C-Protein in Ventricular Myocardium From Patients With Terminal Heart Failure Circulation, January 12, 1999; 99(1): 65 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mahboubi, W. Young, and N. R. Ferreri Tyrosine Phosphatase-Dependent/Tyrosine Kinase-Independent Induction of Nuclear Factor-kappa B by Tumor Necrosis Factor-alpha : Effects on Prostaglandin Endoperoxide Synthase-2 mRNA Accumulation J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 862 - 868. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||